Predictors of progression of recently diagnosed atrial fibrillation in REgistry on cardiac rhythm DisORDers assessing the control of atrial fibrillation (RecordAF)-United States cohort

American Journal of Cardiology

Volumn 112, Issue 1, 2013, Pages 79-84

  Zhang, Yuan Yuan ^a   Qiu, Chunfu ^b   Davis, Pamela J ^c   Jhaveri, Mehul ^b   Prystowsky, Eric N ^d   Kowey, Peter ^e   Weintraub, William S ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b SANOFI   (France)

^c Upsher Smith Laboratories Inc   (United States)

^d St Vincent Medical Group   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE;

AGED; CARDIOVERSION; CATHETER ABLATION; CAUCASIAN; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROPENSITY SCORE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; UNITED STATES;

EID: 84879111170     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.02.056     Document Type: Conference Paper

References (25)

1. C.R. Kerr, K.H. Humphries, M. Talajic, G.J. Klein, S.J. Connolly, M. Green, J. Boone, R. Sheldon, P. Dorian, and D. Newman Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation Am Heart J 149 2005 489 496
2. M. Cohen, and G.V. Naccarelli Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm J Cardiovasc Electrophysiol 19 2008 885 890
3. A. Ruigomez, S. Johansson, M.A. Wallander, and L.A. Garcia Rodriguez Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK BMC Cardiovasc Disord 5 2005 20
4. R. Parkash, M.S. Green, C.R. Kerr, S.J. Connolly, G.J. Klein, R. Sheldon, M. Talajic, P. Dorian, and K.H. Humphries The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation Am Heart J 148 2004 649 654
5. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, J.C. Kellen, H.L. Greene, M.C. Mickel, J.E. Dalquist, and S.D. Corley A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
6. I. van Gelder, V.E. Hagens, H.A. Bosker, J.H. Kingma, O. Kamp, T. Kingma, S.A. Said, J.I. Darmanata, A.J. Timmermans, J.G. Tijssen, and H.J. Crijns A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
7. G.L. Botto, L. Padeletti, M. Santini, A. Capucci, M. Gulizia, F. Zolezzi, S. Favale, G. Molon, R. Ricci, M. Biffi, G. Russo, M. Vimercati, G. Corbucci, and G. Boriani Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events J Cardiovasc Electrophysiol 20 2009 241 248
8. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
9. J.Y. Le Heuzey, G. Breithardt, J. Camm, H. Crijns, P. Dorian, P.R. Kowey, I. Merioua, E.N. Prystowsky, P.J. Schwartz, C. Torp-Pedersen, and W. Weintraub The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation Am J Cardiol 105 2010 687 693
10. A.J. Camm, G. Breithardt, H. Crijns, P. Dorian, P. Kowey, J.Y. Le Heuzey, I. Merioua, L. Pedrazzini, E.N. Prystowsky, P.J. Schwartz, C. Torp-Pedersen, and W. Weintraub Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation) J Am Coll Cardiol 58 2011 493 501
11. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, J.L. Halperin, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, and J.L. Zamorano ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
12. P.R. Kowey, G. Breithardt, J. Camm, H. Crijns, P. Dorian, J.Y. Le Heuzey, L. Pedrazzini, E.N. Prystowsky, G. Salette, P.J. Schwartz, C. Torp-Pedersen, and W. Weintraub Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey Clin Cardiol 33 2010 172 178
13. S.D. Corley, A.E. Epstein, J.P. DiMarco, M.J. Domanski, N. Geller, H.L. Greene, R.A. Josephson, J.C. Kellen, R.C. Klein, A.D. Krahn, M. Mickel, L.B. Mitchell, J.D. Nelson, Y. Rosenberg, E. Schron, L. Shemanski, A.L. Waldo, and D.G. Wyse Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513
14. A.B. Curtis, B.J. Gersh, S.D. Corley, J.P. DiMarco, M.J. Domanski, N. Geller, H.L. Greene, J.C. Kellen, M. Mickel, J.D. Nelson, Y. Rosenberg, E. Schron, L. Shemanski, A.L. Waldo, and D.G. Wyse Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 2005 645 649
15. D.G. Sherman, S.G. Kim, B.S. Boop, S.D. Corley, J.P. DiMarco, R.G. Hart, L.J. Haywood, K. Hoyte, E.S. Kaufman, M.H. Kim, E. Nasco, and A.L. Waldo Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191
16. M.K. Chung, L. Shemanski, D.G. Sherman, H.L. Greene, D.B. Hogan, J.C. Kellen, S.G. Kim, L.W. Martin, Y. Rosenberg, and D.G. Wyse Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) functional status substudy J Am Coll Cardiol 46 2005 1891 1899
17. V.E. Hagens, D.J. van Veldhuisen, O. Kamp, M. Rienstra, H.A. Bosker, N.J. Veeger, J.G. Tijssen, H.J. Crijns, and I.C. van Gelder Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study Heart Rhythm 2 2005 19 24
18. R. Nieuwlaat, M.H. Prins, J.Y. Le Heuzey, P.E. Vardas, E. Aliot, M. Santini, S.M. Cobbe, J.W. Widdershoven, L.H. Baur, S. Levy, and H.J. Crijns Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation Eur Heart J 29 2008 1181 1189
19. A. Jahangir, and S. Murarka Progression of paroxysmal to persistent atrial fibrillation factors promoting the HATCH score J Am Coll Cardiol 55 2010 732 734
20. S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.L. Medvedowsky, and A. Sebaoun Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists Circulation 99 1999 3028 3035
21. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study JAMA 271 1994 840 844
22. A. Capucci, M. Santini, L. Padeletti, M. Gulizia, G. Botto, G. Boriani, R. Ricci, S. Favale, F. Zolezzi, N. Di Belardino, G. Molon, F. Drago, G.Q. Villani, E. Mazzini, M. Vimercati, and A. Grammatico Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers J Am Coll Cardiol 46 2005 1913 1920
23. C.B. de Vos, G. Breithardt, A.J. Camm, P. Dorian, P.R. Kowey, J.Y. Le Heuzey, L. Naditch-Brule, E.N. Prystowsky, P.J. Schwartz, C. Torp-Pedersen, W.S. Weintraub, and H.J. Crijns Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy Am Heart J 163 2012 887 893
24. I. van Gelder, and M.E. Hemels The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm Europace 8 2006 943 949
25. C.B. de Vos, R. Pisters, R. Nieuwlaat, M.H. Prins, R.G. Tieleman, R.J.S. Coelen, A.C. van den Heijkant, and M.A. Allessie Progression from paroxysmal to persistent atrial fibrillation J Am Coll Cardiol 55 2010 725 731